Examining the Impact of Connected Devices on GLP-1 Therapy
![Empowering Digital Health Programs to Make Swift Clinical Decisions](https://withingshealthsolutions.com/wp-content/uploads/2023/10/WITHINGS_2023_LIFESTYLE_LOUIS_BAMFORD_S2_GUYS_5_066-1024x683.webp)
In a March 2024 survey, Withings Health Solutions asked their database of device users about their experience with GLP-1 treatments and the biomarkers they’ve been monitoring throughout their health journey, garnering responses from 2352 participants.